Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

<< < Results 11 - 16 of 16
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.71beta-sitosterol-3-O-glucopyranoside potential of this inhibitor for the treatment of Staphylococcus aureus infections Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.71quercetin-3,3'-dimethyl ether IC50 for recombinant SrtB(DELTA30): 0.0603 mM, no antibacterial activity against Staphylococcus aureus Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.71galangin-3-methyl ether IC50 for recombinant SrtB(DELTA30): 0.1136 mM, no antibacterial activity against Staphylococcus aureus Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.71(Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylonitrile potential of this inhibitor for the treatment of Staphylococcus aureus infections Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.71(Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylonitrile 50% inhibition with 0.0101 mg/ml Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.71psammaplin A1 potential of this inhibitor for the treatment of Staphylococcus aureus infections Go to the Ligand Summary Page
<< < Results 11 - 16 of 16
download as CSV
download all results as CSV